The capacity of type I IFN subtypes to expand tumor-specific CD8+ T cells was investigated in cohorts of C57BL/6 mice inoculated with a single irradiated B16.Kbloss.gB_IFN cell line as a whole-cell vaccine. Here, CD8A is linked to neoplasm.